Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...
Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with ...
Health Canada approves Pr AJOVY® (fremanezumab solution for subcutaneous injection) for the prevention of episodic migraine (fewer than 15 migraine days per month) in pediatric patients aged 6 to 17 ...
Please provide your email address to receive an email when new articles are posted on . Children with growth hormone deficiency assigned long-acting recombinant GH therapy experienced an increase in ...
Board-certified subspecialists in the Division of Pediatric Allergy, Asthma and Immunology specialize in the diagnosis and treatment of children with allergic and immunologic diseases. Allergic ...
The product, lonapegsomatropin, is a sustained-release formulation and could replace daily injections. The FDA recently approved the first once-weekly somatropin injection for pediatric patients 1 ...
IMPAACT 2017 (MOCHA) week 96 results show long-acting Cabenuva (cabotegravir + rilpivirine) effectively maintained viral suppression in 94.4% of adolescents aged 12 to <18 years Additional paediatric ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the first once-weekly formulation of somatropin for children with growth hormone deficiency, ...
The section of Pediatric Orthopaedics provides comprehensive care to patients from birth through 18 years of age. We provide a wide range of services, including the treatment of scoliosis and other ...
MannKind (NasdaqGM:MNKD) is advancing Afrezza toward pediatric use, with the FDA currently reviewing a supplemental Biologics License Application. The company has started the INHALE-1ST clinical study ...
In the U.S., Elucirem is indicated in adults and now in pediatric patients including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal ...